As competitive and regulatory pressures increase, Life Sciences organizations are tightening their timelines and budgets when bringing products to market. In this environment, it’s become essential to start commercialization planning earlier to ensure a successful launch and hit revenue targets. In this deep dive episode, Jen is joined by Vynamic’s Product Launch Service Leads, Ashley Stanley and Brian Stamm, as well as Managing Director of PROPENSITY4, Chris Savage, to discuss why early planning is so critical and how leaders can incorporate some of these changes into their organizations.
To learn more about Vynamic’s work in Product Launch, visit Vynamic’s Product Launch page. To read more on navigating alliance product launches, see Vynamic’s latest insight here.
PROPENSITY4, part of Inizio Engage, is transforming pharmaceutical commercialization through seamless integration of data, expertise and cutting-edge analytics. See more about what PROPENSITY4 can do for your team at Data and Integrated Insights | Inizio Engage.
Podcast Tags: healthcare, life sciences, product launch, healthcare news, life sciences trends, product launch trends
Source Links:
- Product launch challenges and how to overcome them
- Drug launches reflect overall company performance
- TO SPEND OR NOT TO SPEND: Investing For Launch Success As An Emerging Company
- Revenue of the worldwide pharmaceutical market from 2001 to 2023
- Prices for new US drugs rose 35% in 2023, more than the previous year
- Next in pharma 2024: Reinventing for returns
- The Unbearable Cost of Drug Development
- Understanding the Factors that Impact the Pre-Launch Phase and New Product Launch Excellence in the Pharmaceutical Industry
- FDA Approves Many New Drugs in 2023 that Will Benefit Patients and Consumers
Panel – Jen Burke, Ashley Stanley, Chris Savage, Brian Stamm
Research & Production – Adrea Cope & Everly Petruzzelli
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Featured Vynamic Team Members
About Vynamic
Vynamic, an Inizio Advisory company, is a leading management consulting partner to global health organizations across Life Sciences, Health Services, and Health Technology. Founded and headquartered in Philadelphia, Vynamic has offices in Boston, Durham NC, New York, and London. Our purpose is simple: We believe there is a better way. We are passionate about shaping the future of health, and for more than 20 years we’ve helped clients transform by connecting strategy to action.
Through a structured, yet flexible delivery model, our accomplished leaders work as an extension of client teams, enabling growth, performance, and culture. Vynamic has been recognized by organizations like Great Place to Work and Business Culture Awards for being leaders and innovators in consulting, company culture, and health. Visit Vynamic.com to discover how we can help transform your
organization or your career.
Want to learn more? Get in touch!
Related Podcasts:
Felice Walter
Rethinking Launch Planning: Investing Early for Launch Success
Life science organizations often encounter challenges with aligning strategy and execution during a product launch, leading to inefficiencies...
Read more
Felice Walter
Embedding launch excellence as a cultural mindset: Going beyond frameworks, playbooks, and functional checklists to empower teams to focus on what matters most
In today's competitive pharmaceutical environment, the success of product launches hinges on the ability to prioritize outcomes over rigid processes..
Read moreAccounts, Collaboration & Pragmatism: Reuters Pharma Customer Engagement Round-Up
Last month, Life Sciences marketing, commercial and medical leaders from across the country gathered at Reuter’s...
Listen now